InMed Pharmaceuticals Inc.
INM
$1.51
-$0.02-1.31%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.45% | 29.95% | 10.66% | 21.29% | -1.88% |
| Total Depreciation and Amortization | 4.65% | -22.70% | -30.54% | -32.98% | -29.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.23% | -19.02% | -67.87% | -71.13% | 3.90% |
| Change in Net Operating Assets | -445.35% | -381.59% | 57.86% | -63.17% | 118.78% |
| Cash from Operations | 17.89% | -1.77% | -13.70% | -11.18% | -6.09% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 516.47% | 516.47% | 47.13% | 95.93% | -72.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -203.37% | -203.37% | -7.98% | -54.54% | 55.64% |
| Cash from Financing | 96.19% | 831.03% | 105.66% | 163.66% | -11.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.89% | 157.81% | 424.42% | 292.41% | -45.79% |